ShangPharma Innovation

ShangPharma Innovation is a global healthcare investment and incubator organization that facilitates the transition of early-stage therapeutic candidates from academic and research institutions into commercial development. As the innovation arm of the ShangPharma Group, it leverages the extensive R&D capabilities of its affiliate, ChemPartner, to provide portfolio companies with high-quality drug discovery and development services. The company operates innovation centers in South San Francisco and Shanghai, offering a combination of funding, laboratory space, and operational expertise. Its primary focus areas include oncology, immunology, and other high-unmet-need therapeutic categories. By bridging the gap between laboratory research and clinical application, ShangPharma Innovation aims to accelerate the delivery of transformative medicines to patients.